The anticancer drug sotrexoflavone induces autophagy in non-small-cell lung cancer A549 by blocking the PI3K/AKT/mTOR signaling pathway, accelerating A549 cell death [47]. The gene discussed is AKT1; the disease is non-small cell lung carcinoma.